Aziyo Biologics Inc - Ordinary Shares - Class A

NASDAQ:AZYO   3:59:41 PM EDT
13.95
+0.40 (+2.95%)
Earnings Announcements

Aziyo Biologics Reports Q3 Loss Per Share Of $15.79

Published: 11/19/2020 21:22 GMT
(AZYO) - Aziyo Biologics Reports Third Quarter 2020 Financial Results.
Q3 Sales $11.8 Million Versus Refinitiv Ibes Estimate of $11.2 Million.
Q3 Loss per Share $15.79.
Q3 Earnings per Share Estimate $-3.42 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $11.85 Million
Adjusted EPS is expected to be -$0.50

Next Quarter Revenue Guidance is expected to be $11.21 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.